Pacesetter, Inc.

Veritas Ip, LLC

Cliff C Nixon

Paul F Illegems

Eric Christophe Labbe

Andrew Miller Wilder

Scott Darold Hiatt

Steven John Barrus

Various embodiments of an interface control subsystem may be used between an electrode terminal and a recording terminal of a neurostimulation and neurorecording system. The interface control subsystem may operate in three modes. In a disable mode, a first transistor and a second transistor disposed between the electrode terminal and the recording terminal may operate in a cutoff region and generate a high impedance. In an active mode, the first transistor and the second transistor may operate in a saturation region and generate a low impedance. In a stimulation mode, the first transistor and the second transistor operate in a triode region and generate an impedance between the high impedance of the disable mode and the low impedance of the active mode. The interface control subsystem may further limit voltage at the recording terminal in response to a detected overvoltage condition.

Electrical isolation of neurostimulation circuitry from neurorecording circuitry

Described herein are implantable medical devices (IMDs), and methods for use therewith, that enable monitoring of impedance associated with a pathway (e.g., including a lead) used to selectively deliver stimulation pulses to patient tissue. A method involves measuring or storing a first voltage indicative of the energy stored on a reservoir capacitor (Cres) just prior to a stimulation pulse being delivered via the pathway, as well as measuring or storing a second voltage indicative of the energy stored on the Cres just after the stimulation pulse is delivered via the pathway. The method also includes monitoring the impedance associated with the pathway based on a difference between the first and second voltages, which may involve determining a count value indicative of how long it takes to discharge the first voltage to drop to the second voltage, wherein the count value is a surrogate of the impedance associated with the pathway.

Lead impedance monitoring for an implantable medical device

Growing community of inventors

Phoenix, AZ, United States of America

Cliff C Nixon